By: Mike Strahan On July 16, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that has the potential to significantly impact how 340B drugs are handled under Medicare Part D, and by extension, how pharmaceutical rebates are calculated. So, what does that mean? For context: beginning January 1, 2026, CMS is…